|
Real-time Estimate
Cboe BZX
11:40:18 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.6070 USD | +1.15% |
|
-10.47% | -78.75% |
| 10-14 | Tempest Therapeutics, Inc. Announces Appointment of John W. Frederick as Director | CI |
| 10-07 | Sensorion: Louis J. Arcudi III appointed chief financial officer |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 9.93M | - | - | - | - | - |
| 65.83B | |||||
| 51.87B | |||||
| 51.2B | |||||
| 43.76B | |||||
| 42.09B |
Select your edition
All financial news and data tailored to specific country editions
